Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan

被引:40
|
作者
Moriya, K
Shintani, Y
Fujie, H
Miyoshi, H
Tsutsumi, T
Yotsuyanagi, H
Iino, S
Kimura, S
Koike, K
机构
[1] Univ Tokyo, Grad Sch Med, Dept Gastroenterol Internal Med, Bunkyo Ku, Tokyo 1138655, Japan
[2] St Marianna Univ, Sch Med, Dept Gastroenterol & Hepatol, Kawasaki, Kanagawa, Japan
[3] Univ Tokyo, Grad Sch Med, Dept Infect Dis Internal Med, Bunkyo Ku, Tokyo 1138655, Japan
关键词
apolipoprotein; hypocholesterolemia; steatosis; PROLIFERATOR-ACTIVATED RECEPTOR; CORE PROTEIN; HEPATOCELLULAR-CARCINOMA; TRANSGENIC MICE; VIRUS-INFECTION; STEATOSIS; INTERFERON; SECRETION; INCREASE; LIVER;
D O I
10.1016/S1386-6346(02)00309-1
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Hepatitis C virus (HCV) infection is associated with the development of steatosis in the liver. Recently, infection with genotype 3a HCV has been reported to have a closer association with hepatic steatosis than that with genotype 1 or 2 HCV. Moreover, infection with genotype 3a HCV but not with genotype I has been shown to be associated with serum hypocholesterolemia or hypobetalipoproteinemia in European countries. We conducted a case control study to characterize the serum lipid profile in patients infected with genotype 1b HCV, which is the most prevalent HCV genotype in Japan. These patients had significantly lower serum cholesterol levels than those infected with HBV or genotype 2a HCV who had similar liver disease progression and body mass index. Further analysis of serum apolipoproteins revealed that not only apolipoprotein B but also apolipoprotein CII and apolipoprotein CIII levels were significantly reduced, while apolipoprotein AI, AII and E levels were similar in patients infected with genotype 1b HCV and those with HBV or genotype 2a HCV. These results indicate that, in Japan, infection with genotype 1b HCV is a cause of lipid metabolism disturbances, which may be associated with the pathogenesis of hepatitis C liver disease. (C) 2002 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:371 / 376
页数:6
相关论文
共 50 条
  • [21] Daclatasvir plus asunaprevir in treatment-naive patients with hepatitis C virus genotype 1b infection
    Wei, Lai
    Wang, Fu-Sheng
    Zhang, Ming-Xiang
    Jia, Ji-Dong
    Yakovlev, Alexey A.
    Xie, Wen
    Burnevich, Eduard
    Niu, Jun-Qi
    Jung, Yong Jin
    Jiang, Xiang-Jun
    Xu, Min
    Chen, Xin-Yue
    Xie, Qing
    Li, Jun
    Hou, Jin-Lin
    Tang, Hong
    Dou, Xiao-Guang
    Gandhi, Yash
    Hu, Wen-Hua
    McPhee, Fiona
    Noviello, Stephanie
    Treitel, Michelle
    Mo, Ling
    Deng, Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2018, 24 (12) : 1361 - 1372
  • [22] Viral sequence evolution in Chinese genotype 1b chronic hepatitis C patients experiencing unsuccessful interferon treatment
    Xiang, Xiaogang
    Lu, Jie
    Dong, Zhixia
    Zhou, Huijuan
    Tao, Wanyin
    Guo, Qing
    Zhou, Xiaqiu
    Bao, Shisan
    Xie, Qing
    Zhong, Jin
    INFECTION GENETICS AND EVOLUTION, 2011, 11 (02) : 382 - 390
  • [23] Profile of prescription, safety and effectiveness of the new therapies for hepatitis C in patient with genotype 1b
    Valle Corpas, Margarita
    Casas Hidalgo, Inmaculada
    Gonzalez Medina, Maria del Carmen
    Moreno Raya, Patricia
    Moron Romero, Rocio
    Rodriguez Delgado, Alejandro
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2017, 39 (01) : 334 - 335
  • [24] Serum Ceramide Species Are Associated with Liver Cirrhosis and Viral Genotype in Patients with Hepatitis C Infection
    Hoering, Marcus
    Peschel, Georg
    Grimm, Jonathan
    Krautbauer, Sabrina
    Mueller, Martina
    Weigand, Kilian
    Liebisch, Gerhard
    Buechler, Christa
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (17)
  • [25] Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b
    Endo, Daisuke
    Satoh, Kenichi
    Shimada, Noritomo
    Hokari, Atsushi
    Aizawa, Yoshio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (13) : 2355 - 2364
  • [26] Predominance of hepatitis C virus genotype 1b in Bulgaria
    Andonov, A
    Teoharov, P
    Bakalova, S
    EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1996, 15 (06) : 521 - 523
  • [27] Impact of interferon-free antivirus therapy on lipid profiles in patients with chronic hepatitis C genotype 1b
    Daisuke Endo
    Kenichi Satoh
    Noritomo Shimada
    Atsushi Hokari
    Yoshio Aizawa
    World Journal of Gastroenterology, 2017, 23 (13) : 2355 - 2364
  • [28] The safety and efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 1b infection
    Stefan Zeuzem
    Lawrence Serfaty
    John Vierling
    Wendy Cheng
    Jacob George
    Jan Sperl
    Simone Strasser
    Hiromitsu Kumada
    Peggy Hwang
    Michael Robertson
    Janice Wahl
    Eliav Barr
    Rohit Talwani
    Heather Platt
    Journal of Gastroenterology, 2018, 53 : 679 - 688
  • [30] The safety and efficacy of elbasvir and grazoprevir in participants with hepatitis C virus genotype 1b infection
    Zeuzem, Stefan
    Serfaty, Lawrence
    Vierling, John
    Cheng, Wendy
    George, Jacob
    Sperl, Jan
    Strasser, Simone
    Kumada, Hiromitsu
    Hwang, Peggy
    Robertson, Michael
    Wahl, Janice
    Barr, Eliav
    Talwani, Rohit
    Platt, Heather
    JOURNAL OF GASTROENTEROLOGY, 2018, 53 (05) : 679 - 688